Homology of the NH2-terminal Amino Acid Sequences of the Heavy and Light Chains of Human Monoclonal Lupus Autoantibodies Containing the Dominant 16/6 Idiotype
Overview
Affiliations
The NH2-terminal amino acid sequences have been determined by automated Edman degradation for the heavy and light chains of five monoclonal IgM anti-DNA autoantibodies that were produced by human-human hybridomas derived from lymphocytes of two patients with systemic lupus erythematosus. Four of the antibodies were closely related to the idiotype system 16/6, whereas the fifth antibody was unrelated idiotypically. The light chains of the 16/6 idiotype-positive autoantibodies (HF2-1/13b, HF2-1/17, HF2-18/2, and HF3-16/6) had identical amino acid sequences from residues 1 to 40. Their framework structures were characteristic of VKI light chains. The light chain of the 16/6 idiotype-negative autoantibody HF6-21/28 was characteristic of the VKII subgroup. The heavy chains of the 16/6 idiotype-positive autoantibodies had nearly identical amino acid sequences from residues 1 to 40. The framework structures were characteristic of the VHIII subgroup. In contrast, the GM4672 fusion partner of the hybridoma produced small quantities of an IgG with a VHI heavy chain and a VKI light chain. The heavy chains of the lupus autoantibodies and the light chains of those autoantibodies that were idiotypically related to the 16/6 system had marked sequence homology with WEA, a Waldenstrom IgM that binds to Klebsiella polysaccharides and expresses the 16/6 idiotype. These results indicate a striking homology in the amino termini of the heavy and light chains of the lupus autoantibodies studied and suggest that the V regions of the heavy and light chains of the 16/6 idiotype-positive DNA-binding lupus auto-antibodies are each encoded by a single germ line gene.
Foote L, Marshak-Rothstein A, Rothstein T J Exp Med. 1998; 187(6):847-53.
PMID: 9500787 PMC: 2212184. DOI: 10.1084/jem.187.6.847.
Immunoglobulin gene sequence analysis to further assess B-cell origin of multiple myeloma.
Biggs D, Kraj P, Goldman J, Jefferies L, Carchidi C, Anderson K Clin Diagn Lab Immunol. 1995; 2(1):44-52.
PMID: 7719912 PMC: 170099. DOI: 10.1128/cdli.2.1.44-52.1995.
Naparstek Y, Duggan D, Schattner A, Madaio M, Goni F, Frangione B J Exp Med. 1985; 161(6):1525-38.
PMID: 3925065 PMC: 2187620. DOI: 10.1084/jem.161.6.1525.
Colaco C, Scadding G, Lockhart S Clin Exp Immunol. 1987; 68(2):313-9.
PMID: 3498571 PMC: 1542732.
Mackworth-Young C, Sabbaga J, Schwartz R J Clin Invest. 1987; 79(2):572-81.
PMID: 3492514 PMC: 424130. DOI: 10.1172/JCI112849.